Clinical Research Directory
Browse clinical research sites, groups, and studies.
OPTIMISE-CKD Study_Dapagliflozin Effectiveness in CKD
Sponsor: AstraZeneca
Summary
This is a retrospective, observational study, using secondary data captured in electronic health records (EHRs). The study is a part of the OPTIMISE-CKD program to assess the current CKD treatment landscape, Dapagliflozin utilisation and characterization of incident CKD patient and the burden of disease within an observation period of 39 months (August 2020-November 2024) in two cohorts (preand post-reimbursement of Dapagliflozin for CKD)
Official title: A Multinational, Observational, Retrospective, Secondary Data Study Analyzing Dapagliflozin Effectiveness in Routine Clinical Practice Among Patients With Chronic Kidney Disease. Local Adaptation for Spain. Part 2
Key Details
Gender
All
Age Range
18 Years - 130 Years
Study Type
OBSERVATIONAL
Enrollment
14308
Start Date
2026-02-18
Completion Date
2027-02-09
Last Updated
2026-03-27
Healthy Volunteers
No
Conditions
Locations (1)
Research Site
Madrid, Spain